Effects of 3′-deoxynucleoside 5′-triphosphate concentrations on chain termination by nucleoside analogs during human immunodeficiency virus type 1 reverse transcription of minus-strand strong-stop DNA

Journal of Virology

Volumn 70, Issue 2, 1996, Pages 712-720

  Arts, Eric J ^a,b   Marois, James Paul ^a,b   Zhengxian, G U ^a,b   Le Grice, Stuart F J ^c   Wainberg, Mark A ^a,b,d  

^a MCGILL UNIVERSITY   (Canada)

^b MCGILL UNIVERSITY   (Canada)

^c CASE WESTERN RESERVE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^d MCGILL UNIVERSITY   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

DIDANOSINE; LAMIVUDINE; NUCLEOSIDE ANALOG; RNA DIRECTED DNA POLYMERASE; ZIDOVUDINE;

ANTIVIRAL ACTIVITY; ARTICLE; BINDING AFFINITY; DNA SYNTHESIS; HUMAN; HUMAN CELL; HUMAN IMMUNODEFICIENCY VIRUS 1; MONONUCLEAR CELL; POLYMERIZATION; PRIORITY JOURNAL; REVERSE TRANSCRIPTION; TRANSCRIPTION TERMINATION;

ANTIVIRAL AGENTS; BASE SEQUENCE; CELLS, CULTURED; DIDANOSINE; DNA, VIRAL; HIV-1; HUMANS; LAMIVUDINE; MOLECULAR SEQUENCE DATA; NUCLEIC ACID CONFORMATION; NUCLEOSIDES; NUCLEOTIDES; PHYTOHEMAGGLUTININS; RNA, VIRAL; THYMINE NUCLEOTIDES; TRANSCRIPTION, GENETIC; ZALCITABINE; ZIDOVUDINE;

EID: 0030028805     PISSN: 0022538X     EISSN: None     Source Type: Journal    
DOI: 10.1128/jvi.70.2.712-720.1996     Document Type: Article

References (44)

1. Abbotts, J., K. Bebenek, T. A. Kunkel, and S. H. Wilson. 1993. Mechanism of HIV-1 reverse transcriptase, termination of processive synthesis, on a natural DNA template is influenced by the sequence of the template-primer stem. J Biol. Chem. 268:10312-10323.
2. Lys,3 as primers in an endogenous human immunodeficiency virus-I in vitro reverse transcription/ template switching reaction J. Biol Chem 269:14672-14680
3. Arts, E. J., J. Mak, L. Kleiman, and M. A. Wainberg. 1994 DNA found in human immunodeficiency virus type 1 particles may not be required for infectivity J. Gen Virol. 75:1605-1613.
4. Arts, E. J., and M. A. Wainberg. 1994 Preferential incorporation of nucleoside analogs after template switching during human immunodeficiency virus reverse transcription. Antimicrob Agents Chemother. 38:1008-1016.
5. Balzarini, J., P. Herdewijn, and E. De Clerk. 1989 Differential patterns of intracellular metabolism of 2′,3′-dihydro-2′,3′-dideoxythymidine and 3′-azido-2′,3′-dideoxythymidine, two potent anti-human immunodeficiency virus compounds. J Biol. Chem 264:6127-6133,
6. Barat, C., V. Lullien, O. Schatz, G. Keith, M. T. Nugeyre, F. Gruninger-Leitch, F. Barre-Sinoussi, S. F. J. Le Grice, and J. L. Darlix. 1989. HIV-1 reverse transcriptase specifically interacts with the anticodon domain of its cognate primer tRNA. EMBO J. 8:3279-3285.
7. Bebenek, K., J. Abbotts, S. H. Wilson, and T. A. Kunkel. 1993. Error-prone polymerization by HIV-1 reverse transcriptase: contribution of template-primer misalignment, miscoding and termination probability to mutational hot spots. J Biol. Chem. 268:10324-10334.
8. Fischl, M. A., D. D. Richman, M. H. Grieco, M. S. Gottlieb, P. A. Volberding, O. L. Laskin, J. M. Leedom, J. E. Groopman, D. Mildvan, M. S. Hirsh, G. G. Jackson, D. T. Drack, S. Nusinoff-Lehrman, and the AZT Collaborative Working Group. 1987. The efficacy of azidothymidine (AZT) in the treatment of patients with AIDS and AIDS-related complex. N Engl. J. Med. 317:185-191.
9. Furman, P. A., J. A. Fyfe, M. H. St. Clair, K. Weinhold, J. L. Rideout, G. A. Freeman, S. Nusinoff-Lehrman, D. P. Bolognesi, S. Broder, H. Mitsuya, and D. W. Barry. 1986. Phosphorylation of 3′-azido-3′-deoxythymidine and selective interaction of the 5′-triphosphate with human immunodeficiency virus reverse transcriptase. Proc. Natl. Acad. Sci. USA 83:8333-8337.
10. Gao, W.-Y., A. Cara, R. C. Gallo, and F. Lori. 1993. Low levels of deoxynucleotides in peripheral blood lymphocytes a strategy to inhibit human immunodeficiency virus type 1 replication. Proc. Natl. Acad Sci. USA 90:8925-8928.
11. Gao, W.-Y., D. G. Johns, and H. Mitsuya. 1994 Anti-human immunodeficiency virus type 1 activity of hydroxyurea in combination with 2′,3′-didcoxynucleosides. Mol Pharmacol 46:767-772
12. Gao, W.-Y., T. Shirasaka, D. G. Johns, S. Broder, and H. Mitsuya. 1993 Differential phosphorylation of azidothymidine. dideoxycytidine and dideoxyinosine in resting and activated peripheral blood mononuclear cells. J. Clin. Invest. 91:2326-2333
13. Geleziunas, R., E. J. Arts, F. Boulerice, H. Goldman, and M. A. Wainberg. 1993. Effect of 3′-azido-3′-deoxythymidine on human immunodeficiency virus type 1 replication in human fetal brain macrophages. Antimicrob. Agents Chemother. 37:1305-1319.
14. Ghosh, M., K. J. Howard, C. E. Cameron, S. J. Benkovic, S. H. Hughes, and S. F. J. LeGrice. 1995 Truncating α-helix E' of p66 human immunodeficiency virus reverse transcriptase modulates RNase H function and impairs DNA strand transfer. J. Biol. Chem. 270:7068-7076.
15. Gu, Z., E. J. Arts, M. A. Parniak, and M. A. Wainberg. 1995. Mutated K65R recombinant HIV-1 reverse transcriptase showed diminished chain termination with 2′,3′-dideoxycytidine and other drugs. Proc. Natl. Acad. Sci. USA 92:2760-2764.
16. Hart, G. J., D. C. Orr, C. R. Penn, H. T. Figueiredo, N. M. Boehme, and J. M. Cameron. 1992. Effects of (-)-2′-deoxy-3′-thiacytidine (3TC) 5′-triphosphate on human immunodeficiency virus reverse transcriptase and mammalian DNA polymerases alpha, beta, and gamma. Antimicrob Agents Chemother. 36:1688-1694.
17. Heidenreich, O., M. Kruhoffer, F. Grosse, and F. Eckstein. 1990. Inhibition of human immunodeficiency virus 1 reverse transcriptase by 3′-azidothymidine triphosphate. Eur. J. Biochem. 192:621-525.
18. Hirt B. 1967. Selective extraction of polyoma DNA from infected mouse cell cultures. J Mol Biol. 26:365-369.
19. Huang, P., D. Farquhar, and W. Plunkett. 1990. Selective action of 3′-azido-3′-deoxythymidine 5′-triphosphate on viral reverse transcriptases and human DNA polymerases. J. Biol. Chem 265:11914-11918
20. Huber, H. E., J. M. McCoy, J. S. Seehra, and C. C. Richardson. 1989. Human immunodeficiency virus 1 reverse transcriptase: template binding, processivity, strand displacement synthesis, and template switching. J. Biol Chem. 264:4669-4678.
21. Ly3 modulate primer, template loop-loop interactions in the initiation complex of HIV-1 reverse transcriptase. J. Biol. Chem. 268:25269-25272
22. Johnson, M. A., and A. Fridland. 1989 Phosphorylation of 2′,3′-dideoxyinosine by cytosolic 5′-nucleotidase of human lympoid cells. Mol Pharmacol. 36:291-295
23. Klarmann, G. J., C. A. Schauber, and B. D. Preston. 1993. Template-directed pausing of DNA synthesis by HIV-1 reverse transcriptase during polymerization of HIV-1 sequences in vitro J. Biol Chem 268:9793-9802.
24. 23a.Le Grice, S. F. J. Unpublished data.
25. Li, X., J. Mak, E. J. Arts, L. Kleiman, M. A. Wainberg, and M. A. Parniak. 1994 Effects of alterations of primer-binding site sequences on human immunodeficiency virus type 1 replication. J. Virol. 68:6198-6206.
26. Lori, F., A. Malykh, A. Cara, D. Sun, J. N. Weinstein, J. Lisziewicz, and R. C. Gallo. 1994 Hydroxyurea as an inhibitor of human immunodeficiency virus-type 1 replication Science 266:801-805.
27. McGowan, J. J., J. E. Tomaszewski, J. Cardock, D. Hoth, C. K. Grieshaber, S. Broder, and H. Mitsuya. 1990 Overview of the preclinical development of an antiretroviral drug. 2′,3′-dideoxyinosine. Rev. Infect. Dis 12(Suppl 5):S513-S521
28. Mitsuya, H., and S. Broder. 1986 Inhibition of the in vitro infectivity and cytopathic effect of human T-lymphotrophic virus type III/lymphadenopathy-associated virus (HTLV-III/LAV) by 2′,3′-dideoxynucleosides Proc Natl. Acad. Sci. USA 83:1911-1915.
29. Mitsuya, H., K. J. Weinhold, P. A. Furman, M. H. St Clair, S. N. Lehrman, R. C. Gallo, D. Bolognesi, D. W. Barry, and S. Broder. 1985. 3′-Azido-3′-deoxythymidine (BWA509V): an antiviral agent that inhibits the infectivity and cytopathic effects of human T-lymphotropic virus Type III/lymhpadenopathy-associated virus in vitro. Proc. Natl. Acad. Sci. USA 82:7096-7100.
30. Parker, W. B., E. L. White, S. C. Shaddix, L. J. Ross, R. W. Buckheit, Jr., J. M. Germany, J. A. Secrist, R. Vince, and W. M. Shannon. 1991. Mechanism of inhibition of human immunodeficiency virus type 1 reverse transcriptase and human DNA polymerase α, β, and γ by the 5′-triphosphates of carbovir, 3′-azido-3′-deoxythymidine, 2′,3′-dideoxyguanosine, and 3′-deoxythymidine. J Biol. Chem. 266:1754-1762.
31. B) replication in fresh and cultured human peripheral blood monocytes/macrophages by azidothymidine and related 2′,3′-dideoxynucleosides. J. Exp Med. 168:1111-1125.
32. Perno, C.-L., R. Yarchoan, D. A. Cooney, N. R. Hartman, D. S. Webb, Z. Hao, H. Mitsuya, D. G. Johns, and S. Broder. 1989. Replication of human immunodeficiency virus in monocytes: granulocyte/macrophage colony-stimulating factor (GM-CSF) potentiates viral production yet enhances the antiviral effect mediated by 3′-azido-2′,3′-dideoxythymidine (AZT) and other dideoxynucleosides congeners of thymidine. J. Exp. Med. 169:933-951.
33. Reardon, J. E., and W. H. Miller. 1990 Human immunodeficiency virus reverse transcriptase. substrate and inhibitor kinetics with thymidine 5′-triphosphate and 3′-azido-3′-deoxythymidine 5′-triphosphate. J. Biol. Chem. 265:20302-20307.
34. Richman, D., A. S. Rosenthal, M. Skoog, R. J. Eckner, T.-C. Chao, J. B. Sabo, and V. J. Merluzzi. 1991. BI-RG-587 is active against zidovudine-resistant human immunodeficiency virus type 1 and synergistic with zidovudine. Antimicrob Agents Chemother. 35:305-308.
35. Richman, D. D. 1993. HIV drug resistance. Annu. Rev. Pharmacol. Toxicol. 32:149-164.
36. Rozencweig, M., C. McLaren, M. Beltangody, J. Ritter, R. Canetta, L. Schacter, S. Kelley, C. Niscaise, L. Smaldoner, L. Dunkle, R. Barbhaiya, C. Knupp, A. Cross, M. Tsianco, and R. R. Martin. 1990. Overview of phase I trials of 2′,3′-dideoxyinosine (ddI) conducted on adult patients Rev. Intect Dis. 12:S570-S575.
37. Schinazi, R. F., C. K. Chu, A. Peck, A. McMillan, R. Mathis, D. Cannol, L.-S. Jeong, J. W. Beach, W.-B. Choir, S. Yeola, and D. C. Liotta. 1992 Activities of the four optical isomers of 2′3′-dideoxy-3′-thiacytidine (BCH-189) against human immunodeficiency virus type 1 in human lymphocytes Antimicrob Agents Chemother. 36:672-676.
38. Skalka, A. M., and S. P. Goff (ed.). 1993. Reverse transcriptase Cold Spring Harbor Laboratory Press, Cold Spring Harbor, N.Y.
39. Soudeyns, H., X.-Y. Yao, Q. Gao, B. Belleau, J.-L. Kraus, N. Nguyen-Ba, B. Spira, and M. A. Wainberg. 1991. Anti-human immunodeficiency virus type 1 activity and in vitro toxicity of 2′-deoxy-3′-thiacytidine (BCH-189), a novel heterocyclic nucleoside analog. Antimicrob. Agents Chemother. 35:1386-1390.
40. St. Clair, M. H., C. A. Richards, T. Spector, K. J. Weinhold, W. H. Miller, A. J. Langlois, and P. A. Furman. 1987. 3′-Azido-3′-deoxythymidine triphosphate as an inhibitor and substrate of purified human immunodeficiency virus reverse transcriptase. Antimicrob Agents Chemother. 31:1972-1977
41. Wainberg, M. A., Z. Gu, Q. Gao, E. Arts, R. Geleziunas, S. Bour, R. Beaulieu, C. Tsoukas, J. Singer, and J. Montaner. 1993 Clinical correlates and molecular basis of HIV drug resistance. J. Acquired Immune Defic. Syndr 6:S36-S46.
42. Yarchoan, R., C. F. Perno, R. V. Thomas, R. W. Klecker, J.-P. Allain, N. McAtee, R. Dubinsky, H. Mitsuya, T. J. Lawley, B. Safai, C. Myers, C. Perno, R. Klecker, R. Wills, M. Fischl, M. McNeely, J. Pluda, M. Leuther, J. Collins, and S. Broder. 1988. Phase I studies of 2′,3′-dideoxy-cytidine in severe human immunodeficiency virus infection as a single agent and alternating with zidovudine (AZT). Lancet i:76-81.
43. Zack, J. A., S. J. Arrigo, S. R. Weitman, A. S. Go, A. Haislip, and I. S. Y. Chen. 1990. HIV-1 entry into quiescent primary lymphocytes: molecular analysis reveals a labile, latent viral structure. Cell 61:213-222.
44. Zimmermaan, T. P., W. B. Mahoney, and K. L. Prus. 1987. 3′-Azido-3′-deoxythymidine. An unusual nucleoside analogue that permeates the membrane of human erythrocytes and lymphocytes by nonfacilitated diffusion J. Biol. Chem. 262:5748-5754.